Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Momomura, Shin‐ichi; Uchiyama, Shinichiro; Goto, Shinya; Izumi, Tohru; Koretsune, Yukihiro; Kajikawa, Mariko; Kato, Masaharu; Ueda, Hitoshi; Iwamoto, Kazuya; Tajiri, Masahiro; behalf of the J-ROCKET AF study investigators, on

doi:10.1253/circj.cj-12-0454

Public

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

Published in Circulation Journal • Jan 1, 2012

Authors:

Masatsugu Hori

Masayasu Matsumoto

Norio Tanahashi

Abstract

BACKGROUND: The global ROCKET AF study evaluated once-daily rivaroxaban vs. warfarin for stroke and systemic embolism prevention in patients with atrial fibrillation (AF). A separate trial, J-ROCKET AF, compared the safety of a Japan-specific rivaroxaban dose with warfarin administered according to ...

Subject

Rivaroxaban

Medicine

Warfarin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!